Meropy Pharmaceuticals India Private Limited - Company Profile

It is a chemicals private limited company based in Jhansi, Uttar Pradesh, India, established in 2022.
2022 Jhansi, Uttar Pradesh, India Active
Last Updated:
Access Report
About Meropy Pharmaceuticals India Private Limited

Meropy Pharmaceuticals India Private Limited, a active private limited company, was established on 17 November 2022 in Jhansi, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230UP2022PTC173506. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Raj Verma (Director), Adarsh Valmiki (Director). It is based at C/O Kusum Sahu, Narang Bag,Virat Shivaji Nagar Jhansi, Medical (Jhansi), Jhansi, Uttar Pradesh, 284001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230UP2022PTC173506

  • Registration Number

    173506

  • Incorporation Date

    17 November 2022

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 3 Months
Company report

Meropy Pharmaceuticals India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Meropy Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Meropy Pharmaceuticals India Private Limited?
Current Directors
Name Designation Appointment Date Status
Raj Verma Director 17 Nov 2022 Current
Adarsh Valmiki Director 17 Nov 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Meropy Pharmaceuticals India.

Enhance accessibility to Meropy Pharmaceuticals India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Meropy Pharmaceuticals India revenue growth over time
Meropy Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Meropy Pharmaceuticals India?

Unlock access to Meropy Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Meropy Pharmaceuticals India?

Meropy Pharmaceuticals India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Meropy Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meropy Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Meropy Pharmaceuticals India
Recent Activity within the Organization
  • Director Appointment

    Raj Verma was appointed as a Director was appointed as a Director on 17 Nov 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.

  • Director Appointment

    Adarsh Valmiki was appointed as a Director was appointed as a Director on 17 Nov 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Meropy Pharmaceuticals India Private Limited was registered on 17 Nov 2022 with Roc Kanpur & aged 3 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Meropy Pharmaceuticals India Private Limited?

The CIN of Meropy Pharmaceuticals India Private Limited is U24230UP2022PTC173506.

Where is Meropy Pharmaceuticals India Private Limited headquartered?

Meropy Pharmaceuticals India Private Limited is headquartered at C/O Kusum Sahu, Narang Bag,Virat Shivaji Nagar Jhansi, Medical (Jhansi), Jhansi, Uttar Pradesh, 284001.

When was Meropy Pharmaceuticals India Private Limited incorporated?

Meropy Pharmaceuticals India Private Limited was incorporated on 17 November 2022.

Who are the current directors of Meropy Pharmaceuticals India Private Limited?

The current directors of Meropy Pharmaceuticals India Private Limited are

What is the primary industry of Meropy Pharmaceuticals India Private Limited?

The primary industry of Meropy Pharmaceuticals India Private Limited is Chemicals.

Is Meropy Pharmaceuticals India Private Limited a listed company?

Meropy Pharmaceuticals India Private Limited is unlisted.

What is the capital structure of Meropy Pharmaceuticals India Private Limited?

The authorized capital of Meropy Pharmaceuticals India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available